Medical surveillance programme for diisocyanate exposure

Occupational and Environmental Medicine

Volumn 68, Issue 4, 2011, Pages 302-307

  Labrecque, Manon ^a   Malo, Jean Luc ^a   Alaoui, Khadija M ^a   Rabhi, Khalil ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCYANIC ACID DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; COST CONTROL; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH SERVICE; PAINTER; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION; SCREENING; WORKMAN COMPENSATION;

ADULT; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; FEMALE; HUMANS; ISOCYANATES; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; POPULATION SURVEILLANCE; PROGNOSIS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; WORKERS' COMPENSATION;

EID: 79952571299     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oem.2010.055129     Document Type: Article

References (31)

1. Chan-Yeung M, Malo JL. Aetiological agents in occupational asthma. Eur Respir J 1994;7:346-71. (Pubitemid 24138004)
2. Ameille J, Pauli G, Calastreng-Crinquand A, et al. Reported incidence of occupational asthma in France, 1996-99: the ONAP programme. Occup Environ Med 2003;60:136-41.
3. Malo JL. Compensation for occupational asthma in Quebec. Chest 1990;98:236S-9.
4. Tarlo SM, Liss G, Corey P, et al. A workers' compensation claim population for occupational asthma. Comparison of subgroups. Chest 1995;107:634-41.
5. Meyer JD, Holt DL, Chen Y, et al. Surveillance of work-related and occupational respiratory disease in the UK. Occup Med (Lond) 2001;51:204-8. (Pubitemid 32492762)
6. Matte TD, Hoffman RE, Rosenman KD, et al. Surveillance of occupational asthma under the SENSOR Model. Chest 1990;98:173S-8.
7. Padoan M, Pozzato V, Simoni M, et al. Long-term follow-up of toluene diisocyanate-induced asthma. Eur Respir J 2003;21:637-40. (Pubitemid 36432518)
8. Paggiaro PL, Vagaggini B, Bacci E, et al. Prognosis of occupational asthma. Eur Respir J 1994;7:761-7. (Pubitemid 24122975)
9. Paggiaro PL, Vagaggini B, Dente FL, et al. Bronchial hyperresponsiveness and toluene diisocyanate. Long-term change in sensitized asthmatic subjects. Chest 1993;103:1123-8.
10. Paggiaro PL, Loi AM, Rossi O. Follow-up study of patients with respiratory disease due to toluene diisocyanate (TDI). Clin Allergy 1984;14:463-9. (Pubitemid 14040351)
11. Perfetti L, Cartier A, Ghezzo H, et al. Follow-up of occupational asthma after removal from or diminution of exposure to the responsible agent: relevance of the length of the interval from cessation of exposure. Chest 1998;114:398-403. (Pubitemid 28387514)
12. Piirila PL, Nordman H, Keskinen HM, et al. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am J Respir Crit Care Med 2000;162:516-22. (Pubitemid 30647193)
13. Mapp C, Corona PC, de Marzo N, et al. Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate. Am Rev Respir Dis 1988;137:1326-9.
14. Labrecque M, Khemici E, Cartier A, et al. Impairment in workers with isocyanateinduced occupational asthma and removed from exposure in the Province of Québec between 1985 and 2002. J Occup Environ Med 2006;48:1093-8.
15. Bernstein DI, Korbee L, Stauder T, et al. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy & Clin Immunol 1993;92:387-96. (Pubitemid 24088690)
16. Tarlo SM, Banks D, Liss GM, et al. Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup Environ Med 1997;54:756-61. (Pubitemid 27414501)
17. Tarlo SM, Liss GM, Yeung KS. Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup Environ Med 2002;59:58-62. (Pubitemid 34087958)
18. Liss GM, Tarlo SM, Macfarlane Y, et al. Hospitalization among workers compensated for occupational asthma. Am J Respir Crit Care Med 2000;162:112-18. (Pubitemid 30469807)
19. Ott MG, Klees JE, Poche SL. Respiratory health surveillance in a toluene di-isocyanate production unit, 1967-97: clinical observations and lung function analyses. Occup Environ Med 2000;57:43-52.
20. Burney P, Chinn S. Developing a new questionnaire for measuring the prevalence and distribution of asthma. Chest 1987;91:79S-83.
21. Bernstein DI, Campo P, Baur X. Clinical assessment and management of occupational asthma. In: Bernstein IL, Chan-Yeung M, Malo JL, et al, eds. Asthma in the workplace. 3rd edn. New York NY: Taylor & Francis, 2006:161-78.
22. Vandenplas O, Cartier A, Malo JL. Occupational challenge tests. In: Bernstein IL, Chan-Yeung M, Malo JL, et al, eds. Asthma in the workplace. 3rd edn. New York, NY: Taylor & Francis, 2006:227-52.
23. American Thoracic Society. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
24. Cockcroft DW, Killian D, Mellon JJA, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-43. (Pubitemid 8159924)
25. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34. (Pubitemid 13101554)
26. Malo JL, Pineau L, Cartier A, et al. Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population. Am Rev Respir Dis 1983;128:8-11. (Pubitemid 13073530)
27. Bernstein Il, Keskinen H, Blanc PD, et al. Medicolegal aspects, compensation aspects, and evaluation of impairment/disability. In: Bernstein IL, Chan-Yeung M, Malo JL, et al, eds. Asthma in the workplace. 3rd edn. New York NY: Taylor & Francis, 2006:319-51.
28. Kogevinas M, Zock JP, Jarvis D, et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 2007;370:336-41. (Pubitemid 47103209)
29. Wisnewski AV, Redlich CA. Recent Developments in diisocyanate asthma. Curr Opinion Allergy Clin Immunol 2001;1:169-75.
30. Schweigert MK, Mackenzie DP, Sarlo K. Occupational asthma and allergy associated with the use of enzymes in the detergent industry: a review of the epidemiology, toxicology and methods of prevention. Clin Exper Allergy 2000;30:1511-18.
31. Mackie J. Effective health surveillance for occupational asthma in motor vehicle repair. Occup Med(Lond) 2008;58:551-5.